Bernd Kasper, MD, PhD, discusses the key efficacy results from the updated analysis of the phase 3 DeFi trial of nirogacestat in desmoid tumors.

Scientists have turned the same immune response that rejects organ transplants to their advantage – to target cancer. In a trailblazing fusion of immunology and ingenuity, a team of Chinese ...

Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ...

we particularly welcome contributions that focus on the multi-omics pathology of brain tumors and neurodegenerative disorders. Such multidisciplinary approaches hold immense potential for unraveling ...

When detecting tumors, models may overfit due to the distinct differences and variability between different cases, affecting generalization and accuracy. To address these challenges, we propose a ...

Teddi Mellencamp revealed that more tumors have been found in her brain and lungs. On Thursday, March 6, the Real Housewives of Beverly Hills alum, 43, posted a health update to her Instagram ...

Teddi Mellencamp has revealed doctors have discovered five more tumors in her body just weeks after she underwent emergency brain cancer surgery. The former Real Housewives of Beverly Hills ...

Histology was determined from surgical specimen. Conclusion: Histological subtypes can influence the choice of a treatment/therapy for lung cancer patients. We observed that radiomic features show ...

Nam Quoc Bui, MD, discusses survival, symptom control, and ovarian toxicity in the DeFi trial of nirogacestat in patients with desmoid tumors. Balancing Symptoms and Current Therapies in Desmoid Tumor ...